Answers are grounded in this paper and cite their sources.
There is evidence that there is an association between anti-glomerular basement membrane (anti-GBM) antibodies and anti-neutrophil cytoplasmic antibodies (ANCA) in the development of pulmonary renal syndrome (PRS) [1–7]. Whether these two distinct circulating auto-antibodies have some pathological interaction remains unclear. Studies have shown that 30% of patients with anti-GBM disease will test positive for ANCA [1,8]. There is evidence in these studies that the presence of both anti-GBM and ANCA auto-antibodies may lead to a better clinical course than in patients with anti-GBM disease alone regardless of cor p-ANCA specificity. This suggests that dual positivity is not just an epiphenomenon, but may be pathologically linked. Cases of vasculitis developing after anti-GBM disease have been reported, but it is uncertain whether these cases are incidental. We present here a case of anti-GBM glomerulonephritis where a patient had dual positivity of anti-GBM and c-ANCA/PR3 and then 3 years later developed c-ANCA/PR3 associated pauci-immune vasculitis. There are other cases in the literature where patients who have initially been diagnosed with anti-GBM disease subsequently develop p-ANCA/MPO PRS [2–4,7,9]. Most of these cases did not have dual positivity on initial presentation. Our case, included with others, supports a potential link in the underlying disease process leading to both anti-GBM disease and ANCA associated vasculitis that is not related to ANCA specificity.
No takes yet. Share an insight, caveat, or question.
Desai et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: